Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules

被引:37
作者
Zhang, Gengqian [1 ,2 ]
Xu, Sulei [1 ]
Qian, Yan [1 ]
He, Pingnian [1 ]
机构
[1] W Virginia Univ, Dept Physiol & Pharmacol, Sch Med, Morgantown, WV 26506 USA
[2] Shanxi Med Univ, Sch Forens Med, Taiyuan, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2010年 / 299卷 / 05期
关键词
sphingosine-1-phosphate receptors; microvessel permeability; sphingosine-1-phosphate subtype receptor expression; endothelial calcium concentration; SPHINGOSINE 1-PHOSPHATE METABOLISM; SMOOTH-MUSCLE-CELLS; MICROVESSEL PERMEABILITY; VASCULAR-PERMEABILITY; IN-VIVO; BARRIER INTEGRITY; LUNG INJURY; S1P(1); ANGIOGENESIS; CONTRACTION;
D O I
10.1152/ajpheart.00462.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Zhang G, Xu S, Qian Y, He P. Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules. Am J Physiol Heart Circ Physiol 299: H1494-H1504, 2010. First published August 20, 2010; doi:10.1152/ajpheart.00462.2010.-Sphingosine-1-phosphate (S1P) has been demonstrated to enhance endothelial barrier function in vivo and in vitro. However, different S1P receptor subtypes have been indicated to play different or even opposing roles in the regulation of vascular barrier function. This study aims to differentiate the roles of endogenous endothelial S1P subtype receptors in the regulation of permeability in intact microvessels using specific receptor agonist and antagonists. Microvessel permeability was measured with hydraulic conductivity (L-p) in individually perfused rat mesenteric venules. S1P-mediated changes in endothelial intracellular Ca2+ concentration ([Ca2+](i)) was measured in fura-2-loaded venules. Confocal images of fluorescent immunostaining illustrated the spatial expressions of three S1P subtype receptors (S1P(R1-3)) in rat venules. The application of S1P (1 mu M) in the presence of S1P(R1-3) inhibited platelet-activating factor-or bradykinin-induced permeability increase. This S1P effect was reversed only with a selective S1P(R1) antagonist, W-146, and was not affected by S1P(R2) or S1P(R3) antagonists JTE-013 and CAY-10444, respectively. S1P(R1) was also identified as the sole receptor responsible for S1P-mediated increases in endothelial [Ca2+](i). S1P(R2) or S1P(R3) antagonist alone affected neither basal Lp nor platelet-activating factor-induced permeability increase. The selective S1P(R1) agonist, SEW-2871, showed similar [Ca2+](i) and permeability effect to that of S1P. These results indicate that, despite the presence of S1P(R1-3) in the intact venules, only the activation of endothelial S1P(R1) is responsible for the protective action of S1P on microvessel permeability and that endogenous S1P(R2) or S1P(R3) did not exhibit functional roles in the regulation of permeability under basal or acutely stimulated conditions.
引用
收藏
页码:H1494 / H1504
页数:11
相关论文
共 47 条
[1]   PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction [J].
Adamson, RH ;
Zeng, M ;
Adamson, GN ;
Lenz, JF ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01) :H406-H417
[2]  
ADAMSON RH, 2001, CARDIOVASC IN PRESS
[3]   Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy [J].
Awad, AS ;
Huang, LP ;
Ye, H ;
Duong, ETA ;
Bolton, WK ;
Linden, J ;
Okusa, MD .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (04) :F828-F837
[4]   Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference [J].
Chae, SS ;
Paik, JH ;
Furneaux, H ;
Hla, T .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) :1082-1089
[5]  
Curry FE, 1983, CARDIOVASCULAR PHYSL, P1
[6]   Sphingosine 1-phosphate analogs as receptor antagonists [J].
Davis, MD ;
Clemens, JJ ;
Macdonald, TL ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :9833-9841
[7]  
Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI200112450
[8]   Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics [J].
Gonzalez-Cabrera, Pedro J. ;
Hla, Timothy ;
Rosen, Hugh .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (10) :7254-7264
[9]   ENDOTHELIAL-CELL HYPERPOLARIZATION INCREASES [CA2+](I) AND VENULAR MICROVESSEL PERMEABILITY [J].
HE, P ;
CURRY, FE .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 76 (06) :2288-2297
[10]   Effect of nitric oxide synthase inhibitors on endothelial [Ca2+](i) and microvessel permeability [J].
He, P ;
Liu, B ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (01) :H176-H185